17 studies found for:    Open Studies | "Pyelonephritis"
Show Display Options
Rank Status Study
1 Recruiting Antibiotic Prophylaxis in Children With Pyelonephritis
Condition: Pyelonephritis
Interventions: Drug: Trimethoprim Sulfamethoxazole;   Drug: placebo
2 Not yet recruiting Efficacy and Safety Study of Short-term Antibiotic for Pyelonephritis in Women
Condition: Acute Uncomplicated Pyelonephritis
Intervention: Drug: Ceftriaxone
3 Not yet recruiting Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Uncomplicated Pyelonephritis Due to Extended-spectrum β-lactamase Producing Escherichia Coli
Condition: Uncomplicated Pyelonephritis Due to ESBL-producing E.Coli
Intervention: Drug: Cefoxitin
4 Not yet recruiting Community-Associated Uropathogen Antimicrobial Resistance Among Emergency Department Patients With Acute Pyelonephritis
Condition: Pyelonephritis
Intervention: Other: No intervention
5 Recruiting Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Conditions: Complicated Urinary Tract Infection;   Pyelonephritis
Interventions: Drug: CXA-201;   Drug: Levofloxacin
6 Recruiting Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis
Conditions: Complicated Urinary Tract Infection;   Pyelonephritis
Interventions: Drug: CXA-201;   Drug: Levofloxacin
7 Recruiting Prospective Study in the Emergency
Condition: Pyelonephritis
Interventions: Other: care management arm N°1 vs arm N°2;   Other: Care management
8 Recruiting Compare Ceftazidime-Avibactam and Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
Conditions: cUTI;   Complicated Urinary Tract Infection;   Acute Pyelonephritis
Interventions: Drug: CAZ-AVI;   Drug: Doripenem;   Drug: Either switch to oral therapy : 500 mg of Ciprofloxacin (oral);   Drug: or switch to oral therapy : 800 mg/160 mg of sulfamethoxazole/trimethoprim
9 Recruiting Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
Condition: Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis
Interventions: Drug: CAZ-AVI;   Drug: Doripenem;   Drug: Either switch to oral therapy: 500 mg of Ciprofloxacin (oral);   Drug: or switch to oral therapy: 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)
10 Recruiting A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections
Condition: Complicated Urinary Tract Infections or Pyelonephritis
Interventions: Drug: doripenem;   Drug: doripenem placebo;   Drug: cefepime;   Drug: cefepime placebo
11 Not yet recruiting Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria
Conditions: Asymptomatic Bacteriuria;   Pyelonephritis
Interventions: Drug: Antibiotic treatment;   Other: No treatment
12 Recruiting Study of the Safety, Tolerability, and Efficacy of MK-7655 + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for the Treatment of Complicated Urinary Tract Infection (cUTI) (MK-7655-003 AM4)
Conditions: Urinary Tract Infections;   Pyelonephritis
Interventions: Drug: MK-7655 250 mg with imipenem/cilastatin;   Drug: MK-7655 125 mg with imipenem/cilastatin;   Drug: imipenem/cilastatin 500 mg;   Drug: Placebo to MK-7655
13 Unknown  Contrast-Enhanced US of Spleen, Liver and Kidney
Conditions: Malaria;   Pyelonephritis;   Bacterial Infections
Intervention:
14 Not yet recruiting Bacterial and Host Genetic Risk Factors in Acute Pyelonephritis
Condition: Vesicoureteral Reflux
Intervention:
15 Unknown  Urinary Cytokine Levels as a Prognostic Marker for Kidney Scarring After Pyelonephritis
Condition: Kidney Scarring Post-Febrile UTI
Intervention:
16 Recruiting Preventing Urinary Tract Infection Post-Surgery
Condition: Urinary Tract Infection
Intervention: Drug: Cranberry powder
17 Recruiting Febrile Urinary Tract Infection Randomized Short Treatment Trial
Condition: Urinary Tract Infection
Intervention: Drug: short treatment (ciprofloxacin)

Indicates status has not been verified in more than two years